Last edition
News about "osteoarthritis treatment"
Croma-Pharma Acquires Synocrom, Re-Enters Orthopaedics
Croma-Pharma acquires Synocrom to re-enter orthopaedics, expanding its portfolio with a hyaluronic acid treatment for knee osteoarthritis launching in the EU and Switzerland in May 2026.
Osteoarthritis Treatment | 10/04/2026 | By News Bureau
Vascarta's Curcumin Gel Shows Promising Results in Reducing Osteoarthritis Knee Pain
Clinical trial findings reveal significant pain reduction and strong safety profile for investigational topical gel VAS-101 in adults with knee osteoarthritis.
Osteoarthritis Treatment | 02/04/2026 | By News Bureau
Ono Pharmaceutical has signed a definitive agreement with Seikagaku Corporation for the co-development and exclusive marketing of Gel-One for osteoarthritis treatment in Japan.
Osteoarthritis Treatment | 11/08/2025 | By Mrinmoy Dey | 299
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy